Activity of a Long-Acting Injectable Bedaquiline Formulation in a Paucibacillary Mouse Model of Latent Tuberculosis Infection

The potent antituberculosis activity and long half-life of bedaquiline make it an attractive candidate for use in long-acting/extended-release formulations for the treatment of latent tuberculosis infection (LTBI). Our objective was to evaluate a long-acting injectable (LAI) bedaquiline formulation...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Antimicrob Agents Chemother
Auteurs principaux: Kaushik, Amit, Ammerman, Nicole C., Tyagi, Sandeep, Saini, Vikram, Vervoort, Iwan, Lachau-Durand, Sophie, Nuermberger, Eric, Andries, Koen
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2019
Sujets:
Experimental Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6437534/
https://ncbi.nlm.nih.gov/pubmed/30745396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00007-19
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires